FLAG Therapeutics Inc., headquartered in Raleigh, North Carolina, is an early-stage oncology company focused on the development of therapies based on two novel classes of small molecule, water-soluble drugs. In vivo studies suggest that both classes of compounds, antiangiogenic/ anti-tubulin (AA/AT) compounds and folate-targeted anti-cancer (FTAC) compounds, hold the potential to treat multiple cancer types with greater safety and efficacy than conventional therapies. FLAG Therapeutics has obtained exclusive worldwide rights to these compounds from Duquesne University.
View Top Employees from FLAG Therapeutics, Inc.| Website | http://www.flagtherapeutics.com |
| Revenue | $1 million |
| Funding | $500000 |
| Employees | 2 (2 on RocketReach) |
| Founded | 2013 |
| Address | 9168 Wooden Rd, Raleigh, North Carolina 27617, US |
| Phone | (919) 294-6472 |
| Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Pharmaceutical, Business Services, Health Care, Therapeutics |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular FLAG Therapeutics, Inc. employee's phone or email?
FLAG Therapeutics, Inc. Questions
The FLAG Therapeutics, Inc. annual revenue was $1 million in 2024.
Beth Slusar is the Director, Program Management of FLAG Therapeutics, Inc..
2 people are employed at FLAG Therapeutics, Inc..
FLAG Therapeutics, Inc. is based in Raleigh, North Carolina.
The NAICS codes for FLAG Therapeutics, Inc. are [54, 5417, 541, 541714, 54171].
The SIC codes for FLAG Therapeutics, Inc. are [873, 87].
Top FLAG Therapeutics, Inc. Employees
-
23
-
33
Related Companies
